Replies to post #103759 on Biotech Values

[AlpineBV_Miller]

No one is making consequential money from selling interferon for HBV, and BMY won’t be able to either, IMO.

They (Roche) already are, but don't let that get in the way of the argument...

Like I said, this is all a moot point.

We now return you to regularly scheduled MNTA programming...